Related Experiment Video
Updated: May 18, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Pharmacogenetics: transforming clinical medicine
1Genetic Medicine, St Mary's Hospital, Manchester Academic Health Sciences Centre, University of Manchester, Manchester M13 9WL, UK. william.newman@manchester.ac.uk
The Journal of the Royal College of Physicians of Edinburgh
|September 7, 2012
Summary
Pharmacogenetics, the study of genetic variation in drug response, is advancing rapidly. Genetic testing increasingly guides treatment efficacy and toxicity, with future applications in cancer therapy.
Area of Science:
- Pharmacology
- Genetics
- Medicine
Background:
- Pharmacogenetics investigates how inherited genetic variations influence drug responses.
- Understanding these variations is crucial for optimizing therapeutic outcomes and minimizing adverse effects.
Purpose of the Study:
- To review recent advances in pharmacogenetics linking genetic variants to drug efficacy and toxicity.
- To examine the clinical adoption and future trajectory of pharmacogenetic testing.
- To discuss the role of genetic testing in predicting responses to molecularly targeted cancer therapies.
Main Methods:
- Literature review of recent advances in pharmacogenetics.
- Analysis of clinical adoption cases for pharmacogenetic testing.
- Exploration of future trends and applications, including cancer treatment.
Main Results:
- Inherited genetic variants are increasingly associated with drug efficacy and toxicity.
- Pharmacogenetic testing is being integrated into clinical practice.
- Genetic testing of tumor tissues is vital for predicting response to targeted cancer treatments.
Conclusions:
- Pharmacogenetics is a rapidly evolving field with significant clinical implications.
- Future developments will likely expand the use of genetic information in personalized medicine.
- Targeted cancer therapies heavily rely on genetic profiling for treatment selection.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...